Inventor · disambiguated record
Tasir Shamsul Haque
Also filed as: HAQUE TASIR S · HAQUE TASIR SHAMSUL
14 granted patents·5 pending applications·56 citations·filing 2005–2023
90Inventor score
Files withBRISTOL MYERS SQUIBB CO19
Top patents by PatentIndex Score
19 records- 0195US10912766B2[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 9, 2021·6 cites·17 claims
- 0291US11180474B2Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 23, 2021·6 cites·14 claims
- 0391US7417028B2Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditionsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 26, 2008·20 cites·22 claims
- 0486US10660877B2Pyridyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 26, 2020·6 cites·18 claims
- 0586US7534763B2Sustained release GLP-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 19, 2009·5 cites·25 claims
- 0686US2023255941A1[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0785US11447466B2Substituted indole compounds useful as inhibitors of TLR7/8/9BRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 20, 2022·3 cites·7 claims
- 0885US11420958B2Aryl and heteroaryl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 23, 2022·3 cites·9 claims
- 0985US11420973B2Amide substituted indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 23, 2022·3 cites·9 claims
- 1085US11306092B2Amino indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 19, 2022·3 cites·10 claims
- 1175US11672780B2[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jun 13, 2023·0 cites·13 claims
- 1273US7381732B2Pyrazolobenzamides and derivatives as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 3, 2008·1 cites·5 claims
- 1368US11739098B2Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Aug 29, 2023·0 cites·12 claims
- 1456US2008242593A1Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditionsBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 1552US2021253593A1Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1651US2010022457A1Sustained release glp-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 1749US12030878B2Substituted indole ether compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 9, 2024·0 cites·7 claims
- 1846US11878975B2Substituted indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 23, 2024·0 cites·14 claims
- 1945US2007238669A1Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes related conditionsBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tasir Shamsul Haque files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →